Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.60) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.60) per share from the same period last year.
Bio-Rad Laboratories: Q4 Earnings Insights
Bio-Rad Laboratories (NYSE:BIO) reported its Q4 earnings results on Thursday, February 15, 2024 at 04:15 PM. Here’s what…